Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 4/20 | 0.37 |
| ▸ | CTSS | P25774 | 4/20 | 0.36 |
| ▸ | CTSK | P43235 | 4/20 | 0.36 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CTSL | P07711 | 1/20 | 0.35 |
| ▸ | CTSB | P07858 | 1/20 | 0.35 |
| ▸ | REN | P00797 | 3/20 | 0.32 |
| ▸ | CTSD | P07339 | 1/20 | 0.32 |
| ▸ | CTSE | P14091 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9259871 | 0.83 | CYP2D6 (0.40) | CYP2D6CA2CTSSCTSKCAPN1 | |
| SCHEMBL9263938 | 0.82 | CYP2D6 (0.42) | CYP2D6CA2CTSSCTSKCAPN1 | |
| SCHEMBL7412829 | 0.77 | CYP2D6 (0.42) | CYP2D6CA2CTSSCTSKCAPN1 | |
| SCHEMBL9262937 | 0.76 | CYP2D6 (0.41) | CYP2D6CA2CTSSCTSKCA1 | |
| SCHEMBL9270675 | 0.75 | CTSL (0.40) | CYP2D6CTSSCTSKCAPN1CTSL | |
| SCHEMBL9287940 | 0.74 | CD274 (0.47) | CTSKREN | |
| SCHEMBL7345146 | 0.73 | CYP2D6 (0.48) | CYP2D6CA2CTSSCTSKCA1 | |
| SCHEMBL9286028 | 0.72 | ALDH1A1 (0.47) | REN | |
| SCHEMBL7410615 | 0.72 | KMT2A (0.51) | CA2RENCTSDCTSE | |
| SCHEMBL7417716 | 0.71 | BACE1 (0.52) | RENCTSDCTSE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5389647-A | A prodrugs as hypotensive agents, treating congestive heart failure, urogenital disorders, vision defects | ABBOTT LABORATORIES (US) | 1995-02-14 | — | — | US | disclosed |
| US-5244910-A | Treating hypertension, congestive heart failure | ABBOTT LABORATORIES (US) | 1993-09-14 | — | — | US | disclosed |
| WO-1992003429-A1 | RENIN INHIBITORS | ABBOTT LABORATORIES (US) | 1992-03-05 | — | — | WO | disclosed |